• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在重症监护病房用尿素治疗等容量性低钠血症。

Treatment of euvolemic hyponatremia in the intensive care unit by urea.

机构信息

Research Unit on Hydromineral Metabolism, Department of General Internal Medicine, University Erasme Hospital, ULB, Route de Lennik 808, Brussels, B-1070, Belgium.

出版信息

Crit Care. 2010;14(5):R184. doi: 10.1186/cc9292. Epub 2010 Oct 14.

DOI:10.1186/cc9292
PMID:20946646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3219290/
Abstract

INTRODUCTION

Hyponatremia in the intensive care unit (ICU) is most commonly related to inappropriate secretion of antidiuretic hormone (SIADH). Fluid restriction is difficult to apply in these patients. We wanted to report the treatment of hyponatremia with urea in these patients.

METHODS

Two groups of patients are reported. The first one is represented by a retrospective study of 50 consecutive patients with mild hyponatremia treated with urea. The second group is presented by a series of 35 consecutive patients with severe hyponatremia acquired outside the hospital (≤ 115 mEq/L) who where treated by isotonic saline and urea (0.5 to 1 g/kg/day), administered usually by gastric tube.

RESULTS

In the first group with mild hyponatremia (128 ± 4 mEq/L) the serum sodium (SNa) increased to a mean value of 135 ± 4 mEq/L (P < 0.001) after two days of urea therapy (46 ± 25 g/day), despite a large fluid intake (> 2 L/day). The mean duration of urea therapy was six days (from 2 to 42 days). Six patients developed hyponatremia again once the urea was stopped, which necessitated its reintroduction. Six patients developed hypernatremia (maximum value 155 mEq/L). In the second group, SNa increased from 111 ± 3 mEq/L to 122 ± 4 mEq/L in one day (P < 0.001). All the patients with neurological symptoms made a rapid recovery. No side effects were observed.

CONCLUSIONS

These data show that urea is a simple and inexpensive therapy to treat euvolemic hyponatremia in the ICU.

摘要

介绍

重症监护病房(ICU)中的低钠血症最常与抗利尿激素分泌不当(SIADH)有关。在这些患者中,限制液体摄入是困难的。我们报告了在这些患者中使用尿素治疗低钠血症的情况。

方法

报告了两组患者。第一组是对 50 例连续轻度低钠血症患者使用尿素治疗的回顾性研究。第二组是由 35 例连续在院外发生的严重低钠血症患者组成的系列研究(≤115 mEq/L),他们接受等渗盐水和尿素(0.5 至 1 g/kg/天)治疗,通常通过胃管给药。

结果

在轻度低钠血症(128 ± 4 mEq/L)的第一组中,尽管大量液体摄入(>2 L/天),但在接受尿素治疗两天后(46 ± 25 g/天),血清钠(SNa)升高至 135 ± 4 mEq/L 的平均值(P < 0.001)。尿素治疗的平均持续时间为六天(2 至 42 天)。六名患者在停止尿素治疗后再次出现低钠血症,需要重新引入。六名患者出现高钠血症(最高值 155 mEq/L)。在第二组中,SNa 在一天内从 111 ± 3 mEq/L 增加到 122 ± 4 mEq/L(P < 0.001)。所有有神经症状的患者均迅速恢复。未观察到不良反应。

结论

这些数据表明,尿素是治疗 ICU 中容量正常性低钠血症的一种简单且廉价的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1c/3219290/9ec50f4a2782/cc9292-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1c/3219290/a3b01e1b0bd7/cc9292-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1c/3219290/9ec50f4a2782/cc9292-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1c/3219290/a3b01e1b0bd7/cc9292-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1c/3219290/9ec50f4a2782/cc9292-2.jpg

相似文献

1
Treatment of euvolemic hyponatremia in the intensive care unit by urea.在重症监护病房用尿素治疗等容量性低钠血症。
Crit Care. 2010;14(5):R184. doi: 10.1186/cc9292. Epub 2010 Oct 14.
2
Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with urea in critically ill patients.用尿素治疗危重病患者抗利尿激素分泌不当综合征。
Am J Nephrol. 2012;35(3):265-70. doi: 10.1159/000336716. Epub 2012 Feb 23.
3
Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study.噻嗪类药物相关低钠血症,低钠血症登记处报告:一项多中心国际观察性研究。
Am J Nephrol. 2017;45(5):420-430. doi: 10.1159/000471493. Epub 2017 Apr 19.
4
Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy.抗利尿激素分泌不当综合征中的低钠血症。采用尿素、氯化钠及限水疗法进行快速纠正。
JAMA. 1982;247(4):471-4.
5
Urea for the Treatment of Hyponatremia.尿素治疗低钠血症。
Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1627-1632. doi: 10.2215/CJN.04020318. Epub 2018 Sep 4.
6
Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients.静脉输注尿素和生理盐水用于治疗神经外科患者的低钠血症。
J Neurosurg. 1989 Feb;70(2):201-6. doi: 10.3171/jns.1989.70.2.0201.
7
Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.抗利尿激素分泌异常综合征的诊断与治疗
Am J Med. 2016 May;129(5):537.e9-537.e23. doi: 10.1016/j.amjmed.2015.11.005. Epub 2015 Nov 14.
8
Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study.癌症患者的等容性低钠血症。低钠血症登记处报告:一项观察性多中心国际研究。
Support Care Cancer. 2017 Jul;25(7):2275-2283. doi: 10.1007/s00520-017-3638-3. Epub 2017 Mar 2.
9
Comparative Safety and Effectiveness of Urea and Tolvaptan for the Management of Hyponatremia.尿素和托伐普坦治疗低钠血症的安全性和有效性比较。
J Pharm Pract. 2024 Dec;37(6):1252-1257. doi: 10.1177/08971900241247617. Epub 2024 Apr 23.
10
Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.托伐普坦治疗抗利尿激素不适当分泌综合征导致低钠血症的纠正速度。
Am J Kidney Dis. 2018 Jun;71(6):772-782. doi: 10.1053/j.ajkd.2017.12.002. Epub 2018 Feb 23.

引用本文的文献

1
Syndrome of Inappropriate Antidiuresis.抗利尿激素分泌失调综合征
J Am Soc Nephrol. 2025 Apr 1;36(4):713-722. doi: 10.1681/ASN.0000000588. Epub 2024 Dec 2.
2
Clinical factors associated with hyponatremia correction during treatment with oral urea.口服尿素治疗期间与低钠血症纠正相关的临床因素。
Nephrol Dial Transplant. 2025 Feb 4;40(2):283-293. doi: 10.1093/ndt/gfae164.
3
Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD.病例报告:在一例因 SIAD 导致的低钠血症挑战性病例中,采用每日两次托伐普坦给药方案。

本文引用的文献

1
Impact of hospital-associated hyponatremia on selected outcomes.医院获得性低钠血症对特定结局的影响。
Arch Intern Med. 2010 Feb 8;170(3):294-302. doi: 10.1001/archinternmed.2009.513.
2
Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience.静脉注射康维它坦治疗住院患者抗利尿激素不适当分泌综合征引起的低钠血症:单中心经验。
Nephrol Dial Transplant. 2010 May;25(5):1524-31. doi: 10.1093/ndt/gfp731. Epub 2010 Jan 11.
3
Oral urea treatment for polydipsia-hyponatremia syndrome in patients with schizophrenia.
Front Endocrinol (Lausanne). 2024 Jan 15;14:1309657. doi: 10.3389/fendo.2023.1309657. eCollection 2023.
4
Use of Urea for the Syndrome of Inappropriate Secretion of Antidiuretic Hormone: A Systematic Review.使用尿素治疗抗利尿激素分泌不当综合征:系统评价。
JAMA Netw Open. 2023 Oct 2;6(10):e2340313. doi: 10.1001/jamanetworkopen.2023.40313.
5
A randomized controlled trial to assess the effect of isotonic normal saline versus water post-Ryles Tube feeding for correcting hyponatremia among ICU patients at tertiary care hospital: a pilot study.一项随机对照试验,旨在评估三级护理医院重症监护病房(ICU)患者经鼻胃管喂食后使用等渗生理盐水与水纠正低钠血症的效果:一项初步研究。
Int J Physiol Pathophysiol Pharmacol. 2023 Apr 15;15(2):31-40. eCollection 2023.
6
Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management.抗利尿激素分泌不当综合征:从病理生理学到治疗。
Endocr Rev. 2023 Sep 15;44(5):819-861. doi: 10.1210/endrev/bnad010.
7
Hyponatremia Demystified: Integrating Physiology to Shape Clinical Practice.低钠血症解析:生理学整合与临床实践。
Adv Kidney Dis Health. 2023 Mar;30(2):85-101. doi: 10.1053/j.akdh.2022.11.004. Epub 2022 Dec 14.
8
Electrolyte Imbalance and Neurologic Injury.电解质失衡与神经损伤。
CNS Neurol Disord Drug Targets. 2024;23(7):841-851. doi: 10.2174/1871527322666230215144649.
9
Disorders of Salt and Water Balance After Pituitary Surgery.垂体手术后的水盐平衡紊乱。
J Clin Endocrinol Metab. 2022 Dec 17;108(1):198-208. doi: 10.1210/clinem/dgac622.
10
Clinical efficacy of urea treatment in syndrome of inappropriate antidiuretic hormone secretion.尿素治疗抗利尿激素分泌不当综合征的临床疗效。
Sci Rep. 2022 Jun 17;12(1):10266. doi: 10.1038/s41598-022-14387-4.
口服尿素治疗精神分裂症患者的烦渴低钠血症综合征。
J Clin Psychopharmacol. 2009 Oct;29(5):499-501. doi: 10.1097/JCP.0b013e3181b3b38c.
4
Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats.低钠血症快速过度纠正后再诱导低钠血症可降低大鼠死亡率。
Kidney Int. 2009 Sep;76(6):614-21. doi: 10.1038/ki.2009.254. Epub 2009 Jul 15.
5
Hyponatremia in the intensive care unit.重症监护病房中的低钠血症
Semin Nephrol. 2009 May;29(3):257-70. doi: 10.1016/j.semnephrol.2009.03.003.
6
The vaptans ante portas: a status report.血管加压素受体拮抗剂初露端倪:一份现状报告。
Nephrol Dial Transplant. 2009 May;24(5):1371-3. doi: 10.1093/ndt/gfp034. Epub 2009 Feb 13.
7
Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit.在神经重症监护病房中使用考尼伐坦大剂量注射来纠正低钠血症。
Neurocrit Care. 2009;11(1):14-9. doi: 10.1007/s12028-008-9179-3. Epub 2009 Jan 4.
8
The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units.内科-外科重症监护病房中重症监护病房获得性低钠血症和高钠血症的流行病学
Crit Care. 2008;12(6):R162. doi: 10.1186/cc7162. Epub 2008 Dec 18.
9
Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia.口服血管加压素受体拮抗剂考尼伐坦在等容性或高容性低钠血症患者中进行的一项随机对照试验中的疗效与安全性评估。
Am J Med Sci. 2009 Jan;337(1):28-36. doi: 10.1097/MAJ.0b013e31817b8148.
10
Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics.尿酸排泄分数在使用利尿剂的低钠血症患者鉴别诊断中的价值。
J Clin Endocrinol Metab. 2008 Aug;93(8):2991-7. doi: 10.1210/jc.2008-0330. Epub 2008 May 13.